Rituximab Biosimilars News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rituximab biosimilars. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rituximab Biosimilars Today - Breaking & Trending Today

Similar Overall Survival, Shorter Progression-Free Survival With Rituximab Biosimilar in Patients with DLBCL vs Originator

Authors of a single-center, real-world study in Turkey found that patients with diffuse large B-cell lymphoma (DLBCL) who received a rituximab biosimilar had similar overall survival as patients who received the originator. However, progression-free survival was longer in the originator group. ....

International Prognostic Index , Eastern Cooperative Oncology Group , Rituximab Biosimilars ,